biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by ronrydellon Aug 30, 2017 12:19pm

100 Views

Post# 26637527

RE:RE:RE:RE:RE:RE:RE:RE:Information circular...

Great post here, JD for all those impatient (including me) holders of this stock that want instant gratification..The people that lose are the people who have a selfish inability to defer immediate need gratification....as the old saying goes.."All Things come to Those Who Wait"

I hope I'm still saying this three months, six months, or three years from now...it will take extreme discipline....(I'm thirteen years down the pike now with a firm that starts with "R", who has finally gotten on LOI...but will wait for four more months to see what it turns into.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"